References
- KleinJDawsonLAHepatocellular Carcinoma Radiation Therapy: Review of Evidence and Future OpportunitiesInt J Radiat Oncol Biol Phys Epub December 6, 2012
- AravalliRNCressmanENSteerCJCellular and molecular mechanisms of hepatocellular carcinoma: an updateArch Toxicol201387222724723007558
- Della CorteCColomboMSurveillance for hepatocellular carcinomaSemin Oncol201239438439822846857
- PsyrriAArkadopoulosNVassilakopoulouMSmyrniotisVDimitriadisGPathways and targets in hepatocellular carcinomaExpert Rev Anticancer Ther201212101347135723176622
- TovarVAlsinetCVillanuevaAIGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockageJ Hepatol201052455055920206398
- RowinskyEKSchwartzJDZojwallaNBlockade of insulin-like growth factor type-1 receptor with cixutumumab (IMC-A12): a novel approach to treatment for multiple cancersCurr Drug Targets201112142016203321777192
- RowinskyEKYoussoufianHTonraJRSolomonPBurtrumDLudwigDLIMC-A12, a human IgG1 monoclonal antibody to the insulin-like growth factor I receptorClin Cancer Res20071318 Pt 25549s5555s17875788
- KarpDDPaz-AresLGNovelloSPhase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancerJ Clin Oncol200927152516252219380445
- RubinJAyoubNKaldasFSaabSManagement of recurrent hepatocellular carcinoma in liver transplant recipients: a systematic reviewExp C lin Transplant2012106531543
- Abu El MakaremMAn overview of biomarkers for the diagnosis of hepatocellular carcinomaHepat Mon20121210 HCCe612223162601
- TanakaSAriiSMolecular targeted therapies in hepatocellular carcinomaSemin Oncol201239448649222846865